Some trials are focusing on drugs that target the immune system, which is affected by different pathways to long covid.

Researchers looked at biomarkers in study participants and found that those complaining of brain fog had higher levels of an ...

Low-dose naltrexone (LDN) has been identified as a potential treatment for Long COVID after a Griffith University study, ...

Dr. Anil Diwan, President of NanoViricides, Inc. (NYSE Amer.:NNVC ) (the “Company”), comments on the new COVID Vaccine policy adopted by the US FDA.

The global pandemic may have officially waned, but for millions around the world, the aftershocks of COVID-19 remain an ...

“Individuals that experience long COVID report a constellation of symptoms, and these symptoms can be cognitive, they can be ...

Among the more unconventional options for treating long COVID, nicotine – delivered via low-dose transdermal patches – has ...

University of Virginia researchers uncover immune system changes linked to lung damage in Long COVID patients, offering hope for personalized treatments to address lingering respiratory complications.

Long COVID remains a public health concern, with the highest disease risk observed in older adults, women, and those with preexisting conditions or severe acute illness.

“Finding a treatment will be life-changing for patients suffering from the myriad symptoms of Long Covid.” The complexity of Long Covid has made it hard to find a treatment that works for everyon ...

In most people with mild to moderate COVID, it can last 7–10 days. Symptomatic people can spread the infection to others from ...